45 related articles for article (PubMed ID: 38547894)
1. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
[TBL] [Abstract][Full Text] [Related]
2. Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study.
Rapport F; Smith AL; Cust AE; Mann GJ; Watts CG; Gyorki DE; Henderson M; Hong AM; Kelly JW; Long GV; Mar VJ; Morton RL; Saw RP; Scolyer RA; Spillane AJ; Thompson JF; Braithwaite J
BMJ Open; 2020 Feb; 10(2):e032636. PubMed ID: 32111612
[TBL] [Abstract][Full Text] [Related]
3. An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study.
Bertsimas D; Margonis GA; Tang S; Koulouras A; Antonescu CR; Brennan MF; Martin-Broto J; Rutkowski P; Stasinos G; Wang J; Pikoulis E; Bylina E; Sobczuk P; Gutierrez A; Jadeja B; Tap WD; Chi P; Singer S
EClinicalMedicine; 2023 Oct; 64():102200. PubMed ID: 37731933
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
Grossman D; Okwundu N; Bartlett EK; Marchetti MA; Othus M; Coit DG; Hartman RI; Leachman SA; Berry EG; Korde L; Lee SJ; Bar-Eli M; Berwick M; Bowles T; Buchbinder EI; Burton EM; Chu EY; Curiel-Lewandrowski C; Curtis JA; Daud A; Deacon DC; Ferris LK; Gershenwald JE; Grossmann KF; Hu-Lieskovan S; Hyngstrom J; Jeter JM; Judson-Torres RL; Kendra KL; Kim CC; Kirkwood JM; Lawson DH; Leming PD; Long GV; Marghoob AA; Mehnert JM; Ming ME; Nelson KC; Polsky D; Scolyer RA; Smith EA; Sondak VK; Stark MS; Stein JA; Thompson JA; Thompson JF; Venna SS; Wei ML; Swetter SM
JAMA Dermatol; 2020 Sep; 156(9):1004-1011. PubMed ID: 32725204
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes and patterns of recurrence in patients with thin melanoma and a negative sentinel lymph node biopsy: a single-center experience.
Shemer M; Shimonovitz M; Furer R; Abu-Abeid A; Dayan D; Schneebaum S; Miodovnik M; Nizri E
Melanoma Res; 2024 Jun; ():. PubMed ID: 38874499
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?
Liang F; Xin W; Yang S; Wang H
J Gynecol Oncol; 2024 Jun; ():. PubMed ID: 38872479
[TBL] [Abstract][Full Text] [Related]
7. Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas.
Winder AA; Boyer Z; Ch'ng S; Stretch JR; Saw RPM; Shannon KF; Pennington TE; Nieweg OE; Varey AHR; Scolyer RA; Thompson JF; Cust AE; Lo SN; Spillane AJ; Smith AL
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38802717
[TBL] [Abstract][Full Text] [Related]
8. A computed tomography-based multitask deep learning model for predicting tumour stroma ratio and treatment outcomes in patients with colorectal cancer: a multicentre cohort study.
Cui Y; Zhao K; Meng X; Mao Y; Han C; Shi Z; Yang X; Tong T; Wu L; Liu Z
Int J Surg; 2024 May; 110(5):2845-2854. PubMed ID: 38348900
[TBL] [Abstract][Full Text] [Related]
9. Response to Prieto et al, "RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database".
Freeman SC; Paz Munoz E; Latour E; Lim JY; Yu W
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38740332
[No Abstract] [Full Text] [Related]
10. RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database.
Prieto PA; Goldberg MS; Martin B
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38734239
[No Abstract] [Full Text] [Related]
11. [Translated article] Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation.
Tejera-Vaquerizo A; Boada A; Puig S; Nagore E; Fernández-de-Misa R; Ferrándiz L; Conde-Taboada A; Castro E; Richarz NA; Paradela S; Llambrich Á; Salgüero I; Diago A; Samaniego E; Flórez Á; Segura S; Maldonado-Seral C; Coronel-Pérez IM; Tomás-Velázquez A; Rodríguez-Jiménez P; Mayor A; García-Doval I; Grau-Pérez M;
Actas Dermosifiliogr; 2024 May; ():. PubMed ID: 38821354
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in postoperative patients with cutaneous melanoma: a systematic review and meta-analysis.
Xia Q; Ma Q; Zhu J; Gu L; Zhou F
Am J Cancer Res; 2024; 14(5):1947-1956. PubMed ID: 38859868
[TBL] [Abstract][Full Text] [Related]
13. A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence.
Perez M; Palnaes Hansen C; Burdio F; Sanchez-Velázquez P; Giuliani A; Lancellotti F; de Liguori-Carino N; Malleo G; Marchegiani G; Podda M; Pisanu A; De Luca GM; Anselmo A; Siragusa L; Kobbelgaard Burgdorf S; Tschuor C; Cacciaguerra AB; Koh YX; Masuda Y; Hao Xuan MY; Seeger N; Breitenstein S; Grochola FL; Di Martino M; Secanella L; Busquets J; Dorcaratto D; Mora-Oliver I; Ingallinella S; Salvia R; Abu Hilal M; Aldrighetti L; Ielpo B
Eur J Surg Oncol; 2024 May; 50(7):108375. PubMed ID: 38795677
[TBL] [Abstract][Full Text] [Related]
14. Multivariable prognostic modelling to improve prediction of colorectal cancer recurrence: the PROSPeCT trial.
Goh V; Mallett S; Boulter V; Glynne-Jones R; Khan S; Lessels S; Patel D; Prezzi D; Rodriguez-Justo M; Taylor SA; Beable R; Betts M; Breen DJ; Britton I; Brush J; Correa P; Dodds N; Dunlop J; Gourtsoyianni S; Griffin N; Higginson A; Lowe A; Slater A; Strugnell M; Tolan D; Zealley I; Halligan S;
Eur Radiol; 2024 Jun; ():. PubMed ID: 38836939
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Svedman FC; Pillas D; Taylor A; Kaur M; Linder R; Hansson J
Clin Epidemiol; 2016; 8():109-22. PubMed ID: 27307765
[TBL] [Abstract][Full Text] [Related]
16. Statin use does not impact sentinel lymph node metastasis and recurrence in melanoma patients: an 844-patient retrospective study.
Jing FZ; Pazhava A; Todd A; Meves A; Yu WY
Int J Dermatol; 2024 Jun; ():. PubMed ID: 38867411
[No Abstract] [Full Text] [Related]
17. Clinicopathological and Molecular Features of Penile Melanoma With a Proposed Staging System.
Cornejo KM; Goyal A; Valencia Guerrero A; Astudillo M; Dias-Santagata D; Johnson MM; Feldman AS; Hoang MP
Am J Surg Pathol; 2024 May; ():. PubMed ID: 38808927
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
